SCHEMBL281979

SCHEMBL281979

O=C(Cl)c1sccc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4337185 0.81
SCHEMBL154710 0.81
SCHEMBL155500 0.79
SCHEMBL5424332 0.79
Hydrochloric Acid SCHEMBL940187 0.79 MAPT (0.50)
SCHEMBL2225907 0.79
Hydrazine SCHEMBL27615552 0.77 MAPT (0.49)
SCHEMBL1859781 0.77 GAA (0.69)
SCHEMBL5215746 0.77 MAPT (0.49)
SCHEMBL7219923 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 287 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250380697-A1 ISOXAZOLINE DERIVATIVE COMPOUND AND INSECTICIDAL COMPOSITION COMPRISING SAME KYUNG NONG CORPORATION (KR) 2025-12-18 US disclosed
US-10450280-B2 Tetrazolones as a carboxylic acid bioisosteres RIGEL PHARMACEUTICALS, INC. (US) 2019-10-22 US disclosed
US-10450280-B2 Tetrazolones as a carboxylic acid bioisosteres RIGEL PHARMACEUTICALS, INC. (US) 2019-10-22 US disclosed
EP-3250565-B1 TETRAZOLONES AS CARBOXYLIC ACID BIOISOSTERES RIGEL PHARMACEUTICALS INC (US) 2019-07-03 EP disclosed
EP-3250565-B1 TETRAZOLONES AS CARBOXYLIC ACID BIOISOSTERES RIGEL PHARMACEUTICALS INC (US) 2019-07-03 EP disclosed
US-20190070149-A1 PRIMARY AMINES AND DERIVATIVES THEREOF AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. 2019-03-07 US disclosed
US-10071994-B2 N-sulfonyl homoserine lactone derivatives, preparation method and use thereof INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES P.L.A. CHINA (CN) 2018-09-11 US disclosed
US-20180179193-A1 N-Sulfonyl Homoserine Lactone Derivatives, Preparation Method and Use Thereof INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES P.L.A. CHINA (CN) 2018-06-28 US disclosed
US-9987252-B2 Primary amines and derivitves thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto ARENA PHARMACEUTICALS, INC. (US) 2018-06-05 US disclosed
US-20180002297-A1 Tetrazolones as a Carboxylic Acid Bioisosteres MIDCAP FINANCIAL TRUST 2018-01-04 US disclosed
EP-0000649-B1 5-SUBSTITUTED-1,2-DIHYDRO-3H-PYRROLO(1,2-A)PYRROLE-1-CARBONITRILES AND PROCESS FOR THEIR CONVERSION TO THE CORRESPONDING 1-CARBOXYLIC ACIDS SYNTEX (U.S.A.) INC. (US) 1981-03-25 EP disclosed
US-4230873-A Thiophene derivatives HOFFMANN-LA ROCHE INC. (US) 1980-10-28 US disclosed
US-4224445-A ANTIINFLAMMATORY, ANALGESIC, ANTIRHEUMATIC HOFFMANN-LA ROCHE INC. (US) 1980-09-23 US disclosed
US-4177193-A ALKOXYCARBONYL, ALKYLAMINOSULFONYL-SUBSTITUTED THIOPHENE INTERMEDIATES FOR THE 4-HYDROXY-N-SUBSTITUTED-2H-THIENO(2,3-E)-1,2-THIAZINE-3-CARBOXAMIDE-1,1 -DIOXIDES; ANTIINFLAMMATORY, ANALGESIC HOFFMAN-LA ROCHE INC. (US) 1979-12-04 US disclosed
US-4175085-A ANTIINFLAMMATORY, ANALGESIC, ANTIRHEUMATIC HOFFMANN-LA ROCHE INC. (US) 1979-11-20 US disclosed
US-4140698-A 1,2-Dihydro-3H-pyrrolo[1,2-a]pyrrole-1-nitriles SYNTEX (USA) INC. (US) 1979-02-20 US disclosed
EP-0000649-A1 5-substituted-1,2-dihydro-3H-pyrrolo(1,2-a)pyrrole-1-carbonitriles and process for their conversion to the corresponding 1-carboxylic acids SYNTEX (U.S.A.) INC. (US) 1979-02-07 EP disclosed
US-4134898-A ANTIINFLAMMATORY, ANALGESIC, ANTIRHEUMATIC HOFFMANN-LA ROCHE INC. (US) 1979-01-16 US disclosed
US-4090020-A ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTIRHEUMATIC AGENTS HOFFMANN-LA ROCHE INC. (US) 1978-05-16 US disclosed
US-4076709-A ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTIRHEUMATIC AGENTS HOFFMANN-LA ROCHE INC. (US) 1978-02-28 US disclosed